Table 2.
ICH features | Crude |
Adjusted |
||||||
---|---|---|---|---|---|---|---|---|
β | 95% CI | p value | β | 95% CI | p value | |||
Lobar location | 4.181 | 2.730 | 5.632 | <0.001 | 0.8269 | –0.7504 | 2.4041 | 0.304 |
Volume, mL | 1.588 | 1.165 | 2.011 | <0.001 | 0.2888 | –0.2274 | 0.8050 | 0.273 |
Irregular shape | 3.787 | 2.931 | 4.644 | <0.001 | 2.5545 | 1.6466 | 3.4624 | <0.001 |
Heterogeneous density | 2.050 | 1.159 | 2.942 | <0.001 | 0.9493 | 0.0279 | 1.8708 | 0.044 |
Intraventricular extension | 1.162 | 0.203 | 2.120 | 0.018 | 0.3953 | –0.5675 | 1.3580 | 0.421 |
Subarachnoid extension | 7.268 | 5.703 | 8.833 | <0.001 | 5.1520 | 3.4574 | 6.8466 | <0.001 |
White matter lesion | 0.968 | 0.086 | 1.850 | 0.031 | 0.6005 | –0.2923 | 1.4933 | 0.187 |
Atrophy | –0.339 | –1.483 | 0.805 | 0.562 | –1.8004 | –3.0520 | –0.5488 | 0.005 |
CI, confidence interval. Volume data were log transformed. Model adjusted for age, sex, ethnicity, high National Institutes of Health Stroke Scale score (<14 vs. ≥14), and history of ischemic stroke, hypertension, and antithrombotic use.